Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer

被引:72
作者
Frederick, L. A. [1 ]
Matthews, J. A. [1 ]
Jamieson, L. [1 ]
Justilien, V. [1 ]
Thompson, E. A. [1 ]
Radisky, D. C. [1 ]
Fields, A. P. [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA
关键词
non-small cell lung cancer; Rac1; PB1; domain; cellular invasion; anchorage-independent growth;
D O I
10.1038/onc.2008.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase C iota (PKC iota) drives transformed growth of non-small cell lung cancer (NSCLC) cells through the Rho family GTPase Rac1. We show here that PKC iota activates Rac1 in NSCLC cells by formation of a PKC iota-Par6 alpha complex that drives anchorage-independent growth and invasion through activation of matrix metalloproteinase-10 (MMP-10) expression. RNAi-mediated knockdown of PKC iota, Par6 alpha or Rac1 expression inhibits NSCLC transformation and MMP-10 expression in vitro. Expression of wild-type Par6 alpha in Par6 alpha-deficient cells restores transformation and MMP-10 expression, whereas expression of Par6 alpha mutants that either cannot bind PKC iota (Par6 alpha-K19A) or couple to Rac1 (Par6 alpha-Delta CRIB) do not. Knockdown of MMP-10 expression blocks anchorage-independent growth and invasion of NSCLC cells and addition of catalytically active MMP-10 to PKC iota- or Par6 alpha-deficient cells restores anchorage-independent growth and invasion. Dominant-negative PKC iota inhibits tumorigenicity and MMP-10 expression in subcutaneous NSCLC tumors. MMP-10 and PKC iota are coordinately overexpressed in primary NSCLC tumors, and tumor MMP-10 expression predicts poor survival in NSCLC patients. Our data define a PKC iota-Par6 alpha-Rac1 signaling axis that drives anchorage-independent growth and invasion of NSCLC cells through induction of MMP-10 expression.
引用
收藏
页码:4841 / 4853
页数:13
相关论文
共 26 条
[1]  
Bodey B, 2001, IN VIVO, V15, P175
[2]   MMP expression profiling in recurred stage IB lung cancer [J].
Cho, NH ;
Hong, KP ;
Hong, SH ;
Kang, S ;
Chung, KY ;
Cho, SH .
ONCOGENE, 2004, 23 (03) :845-851
[3]  
Delebecq TJ, 2000, CLIN CANCER RES, V6, P1086
[4]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[5]   Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Cι [J].
Erdogan, Eda ;
Lamark, Trond ;
Stallings-Mann, Melody ;
Jamieson, Lee ;
Pellechia, Mauricio ;
Thompson, E. Aubrey ;
Johansen, Terje ;
Fields, Alan P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (38) :28450-28459
[6]   Protein kinase Cι:: Human oncogene, prognostic marker and therapeutic target [J].
Fields, Alan P. ;
Regala, Roderick P. .
PHARMACOLOGICAL RESEARCH, 2007, 55 (06) :487-497
[7]   Diversity of gene expression in adenocarcinoma of the lung [J].
Garber, ME ;
Troyanskaya, OG ;
Schluens, K ;
Petersen, S ;
Thaesler, Z ;
Pacyna-Gengelbach, M ;
van de Rijn, M ;
Rosen, GD ;
Perou, CM ;
Whyte, RI ;
Altman, RB ;
Brown, PO ;
Botstein, D ;
Petersen, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13784-13789
[8]   MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas [J].
Gill, JH ;
Kirwan, IG ;
Seargent, JM ;
Martin, SW ;
Tijani, S ;
Anikin, VA ;
Mearns, AJ ;
Bibby, MC ;
Anthoney, A ;
Loadman, PM .
NEOPLASIA, 2004, 6 (06) :777-785
[9]   SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus [J].
Imoto, I ;
Pimkhaokham, A ;
Fukuda, Y ;
Yang, ZQ ;
Shimada, Y ;
Nomura, N ;
Hirai, H ;
Imamura, M ;
Inazawa, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 286 (03) :559-565
[10]   Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer [J].
Impola, U ;
Uitto, VJ ;
Hietanen, J ;
Hakkinen, L ;
Zhang, L ;
Larjava, H ;
Isaka, K ;
Saarialho-Kere, U .
JOURNAL OF PATHOLOGY, 2004, 202 (01) :14-22